CYNTHIA BAER: Open Payments
NPI 1770564270 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,931 in 154 payments from 33 companies in 2025. Trend: 2023 $4,199 · 2024 $4,042 · 2025 $3,931
Food & beverage: $3,931
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $714 |
| Axsome Therapeutics, Inc. | 9 | $337 |
| Novo Nordisk Inc | 12 | $309 |
| Lilly USA, LLC | 12 | $270 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 18 | $263 |
| ViiV Healthcare Company | 6 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $200 |
| Amgen Inc. | 13 | $184 |
| GlaxoSmithKline, LLC. | 12 | $161 |
| Boston Scientific Corporation | 1 | $142 |
Products named: VRAYLAR, JARDIANCE, Auvelity, Ozempic, Kerendia, APRETUDE, QULIPTA, General - Therapies.
Industry payments across CA — which companies pay providers there.
